Accueil
Replek logo
Replek

À Propos de l'Entreprise

  • Raison sociale: Replek
  • Nom international: Replek AD Skopje, North Macedonia
  • Marque / Nom commercial: Replek
  • Pays d'enregistrement: North Macedonia
  • Adresse: Kozle str. No. 188, Skopje
  • Nombre d'employés: 250 - 499
Description:

Replek is a prominent Macedonian-Austrian pharmaceutical company based in North Macedonia with a rich history spanning more than 80 years. As a leader in the Macedonian pharmaceutical market, Replek produces high-quality generic medicines including tablets, capsules, oral solutions, creams and ointments, recognized for its commitment to innovation, modernization and the well-being of consumers, employees and shareholders; as the country's oldest distributor, Replek also provides full regulatory, marketing and sales support.

Activités Commerciales

Compléments Alimentaires & Nutraceutiques

Fournisseur

Dispositifs & Équipements Médicaux

Distributeur

Extraits Naturels & Ingrédients Botaniques

Fabricant

Services de Conditionnement à Façon

Fabricant

Classification ATC (Anatomique, Thérapeutique, Chimique)

Fabricant

Systèmes d'Administration de Médicaments

Fabricant

Formes Pharmaceutiques Finies

Fabricant
Marchés de Vente

Nos Produits & Services

Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "Neuro-Vit®"
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "Rekonazol shampoo"
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "GINOFIX®"
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "Revagra® Tablets"
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "Oralsept® spray"
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "RESIN spray"
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Replek sell "REMIG spray"

Certifications

GMP

ISO

Proofs

CPHI Milan 2026
CPHI Milan 2026
10/2026 – 10/2026

CPHI Milan 2026

Lieu
Fiera Milano, Italy
Filtres :
Trier par :

    Aucun commentaire disponible.